Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription Articles published in PLoS One Retrieve available abstracts of 248 articles: HTML format

Single Articles

January 2026
1. QIU L, Xie Y, Li Y, Huang J, et al
   Association between serum gamma-Glutamyltransferase and the risk of cervical cancer: Evidence from the national health and nutrition examination survey.
   PLoS One. 2026;21:e0339001.
   PubMed     Abstract available
   
   
   
2. HU J, Wang Y, Liu Y, Cai Z, et al
   Global burden and projections of cervical cancer attributable to unsafe sex and smoking, 1990-2034.
   PLoS One. 2026;21:e0339923.
   PubMed     Abstract available
   
   
   
3. TANIOKA M, Nagao S, Ida N, Tanaka Y, et al
   Fertility-sparing surgery with neoadjuvant chemotherapy in early and locally advanced cervical cancer: A clinical protocol.
   PLoS One. 2026;21:e0340963.
   PubMed     Abstract available
   
   
   
4. WANZALA J, Anino CO
   Uptake of cervical cancer screening and its associated factors among women of reproductive age in Kericho County.
   PLoS One. 2026;21:e0328614.
   PubMed     Abstract available
   
   
   
5. PROIETTI A, De Angelis E, Buccini L, Leopizzi M, et al
   A pilot multimodal study of cervical cancer: Raman spectroscopy as a molecular fingerprint tool.
   PLoS One. 2026;21:e0327286.
   PubMed     Abstract available
   
   
   
6. ILIC I, Babic G, Sipetic Grujicic S, Zivanovic Macuzic I, et al
   Concurrent depression and anxiety in women undergoing additional diagnostic procedures due to positive screening for cervical cancer.
   PLoS One. 2026;21:e0342492.
   PubMed     Abstract available
   
   
   
7. HADDADI M, Golestani A, Farzi Y, Rezaei N, et al
   Iran is falling behind WHO cervical cancer elimination targets: HPV vaccination coverage and cervical cancer screening participation in 2021.
   PLoS One. 2026;21:e0341888.
   PubMed     Abstract available
   
   
   
8. KIM WJ, Kim YW
   Association between cervical conization and pregnancy outcomes: A nationwide population-based cohort study.
   PLoS One. 2026;21:e0341660.
   PubMed     Abstract available
   
   
   
9. 
   Retraction: Design and validation of ultra-compact metamaterial-based biosensor for non-invasive cervical cancer diagnosis in terahertz regime.
   PLoS One. 2026;21:e0343674.
   PubMed    
   
   
   
10. ARMIJO N, Espinoza MA, Contreras-Montiel P, Vera M, et al
    Cost-effectiveness of primary HPV genotyping and dual-stain or cytology reflex testing versus cytology-based screening for cervical cancer in Chile.
    PLoS One. 2026;21:e0332010.
    PubMed     Abstract available
    
    
    
11. CUPERTINO BERGOMI L, de Souza Carvalho G, Zanetti de Albuquerque L, Goncalves Kischinhevsky D, et al
    Social inequities and clinical outcomes in young women with cervical cancer: Real-world evidence.
    PLoS One. 2026;21:e0343651.
    PubMed     Abstract available
    
    
    
12. CHEN Y, Qiu W, Xiao G, Zhang R, et al
    Analysis of the correlation between vaginal microbiota and high-risk human papillomavirus infection and cervical lesions.
    PLoS One. 2026;21:e0343027.
    PubMed     Abstract available
    
    
    
13. MITCHELL LE, Phillips E, Jennett CJ, Bavor C, et al
    Experiences of HPV self-collection among Aboriginal and Torres Strait Islander women and people with a cervix.
    PLoS One. 2026;21:e0326551.
    PubMed     Abstract available
    
    
    
14. HASBAY E, Sahin S, Kelten Talu EC, Sanci M, et al
    MRI differentiation of usual type endocervical adenocarcinoma and cervical squamous cell carcinoma.
    PLoS One. 2026;21:e0343764.
    PubMed     Abstract available
    
    
    
15. AYASS MA, Zaman N, Griko N, Pashkov V, et al
    Non-invasive host transcriptome and HPV oncogene expression map the molecular landscape of HPV-driven cervical lesions.
    PLoS One. 2026;21:e0339693.
    PubMed     Abstract available
    
    
    
16. AFAYA A, Awunyo W, Udeoha MA, Kodjo MM, et al
    The relational association between multiple sexual partners and HIV testing on cervical cancer screening among women of reproductive age in Ghana: A national population-based study.
    PLoS One. 2026;21:e0344086.
    PubMed     Abstract available
    
    
    
17. WU Q, Bai S, Wang P, Han L, et al
    Limonin induces ferroptosis in cervical squamous cell carcinoma by activating the expression of soluble epoxide hydrolase 2 protein.
    PLoS One. 2026;21:e0343495.
    PubMed     Abstract available
    
    
    
18. DAY S, Harries J, Sawula B, Payne A, et al
    Navigating cancer: Insights from patient journey mapping.
    PLoS One. 2026;21:e0327113.
    PubMed     Abstract available
    
    
    
19. YAN K, Yang G, Yan L, Wu L, et al
    Global trends and forecasts of cervical cancer and a real-world safety assessment of human papillomavirus vaccines in women: A systematic analysis of the Global Burden of Disease study 2021 and the Vaccine Adverse Event Reporting System database.
    PLoS One. 2026;21:e0345286.
    PubMed     Abstract available
    
    
    
20. SHIRAKAWA S, Nagao S, Yoshio K, Mitsuhashi T, et al
    Incidence of pelvic fractures after definitive radiotherapy for cervical cancer: A retrospective multicenter cohort study (The IPFAR study).
    PLoS One. 2026;21:e0344384.
    PubMed     Abstract available
    
    
    
21. EMESU G, Kiracho EE, Jatho A, Kagaayi J, et al
    Equity in awareness and utilization of cervical cancer screening services among women of reproductive age in Uganda: Analysis of vertical equity using evidence from UDHS 2022.
    PLoS One. 2026;21:e0335336.
    PubMed     Abstract available
    
    
    
22. WHOP LJ, Mitchell LE, Butler TL, Wong D, et al
    Screen Your Way Study Protocol: Embedding community driven models to increase cervical screening via HPV self-collection to improve cervical cancer outcomes for Aboriginal and Torres Strait Islander people.
    PLoS One. 2026;21:e0336004.
    PubMed     Abstract available
    
    
    
23. ASSEFA KT, Worku AG, Muche AA, Geremew BM, et al
    Geographic inequities in human papillomavirus vaccine non-uptake and its determinants among adolescent girls in Ethiopia: Evidence from the National Immunization Survey.
    PLoS One. 2026;21:e0348076.
    PubMed     Abstract available
    
    
    
24. BITEWA MD, Yewodiaw TK, Abneh AA, Molla MG, et al
    Determinants of cervical cancer screening among women aged 30 to 49 years in 20 low- and middle-income countries: A multilevel analysis.
    PLoS One. 2026;21:e0347837.
    PubMed     Abstract available
    
    
    
25. TILAHUN SW, Nega A, Wagaw L, Addissie A, et al
    Shared decision-making in Cervical Cancer Care at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A mixed-methods study.
    PLoS One. 2026;21:e0348172.
    PubMed     Abstract available
    
    
    
26. ESSAYAGH T, Essayagh M, Nmila K, Slibani H, et al
    Prevalence and determinants of parental refusal of human papillomavirus vaccination in Morocco: A multicenter cross-sectional study.
    PLoS One. 2026;21:e0348586.
    PubMed     Abstract available
    
    
    
27. ESSAYAGH T, Essayagh M, Slibani H, El Hachimi S, et al
    Challenges to human papillomavirus vaccination among young girls in Morocco: A national cross-sectional study.
    PLoS One. 2026;21:e0347783.
    PubMed     Abstract available
    
    
    
28. SALDANHA DA SILVA RL, Cardoso Mendes SR, Silva de Brito B, Pimentel de Moura B, et al
    Cervical cancer: Riverside women's knowledge in the Brazilian Amazon about preventive measures.
    PLoS One. 2026;21:e0347609.
    PubMed     Abstract available
    
    
    
29. ROMLI R, Mohammed Nawi A, Abd Rahman R, Mohamad EMW, et al
    Digital motivation for cervical cancer screening: A quasi-experimental trial of the SeDAR Video among middle adulthood Malaysian women.
    PLoS One. 2026;21:e0347489.
    PubMed     Abstract available
    
    
    
30. BUTTA J, Thonghoi P, Kesakul T, Thoopthong A, et al
    Incremental impact of community-delivered HPV self-sampling on screening uptake within an active outreach system: A quasi-experimental implementation study in rural Thailand.
    PLoS One. 2026;21:e0349531.
    PubMed     Abstract available
    
    
    
31. YANG S, Hou Y, Wang X, Kang S, et al
    Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis.
    PLoS One. 2026;21:e0351029.
    PubMed     Abstract available
    
    
    
32. CHEN S, Yang X, Jiang S, Lin Y, et al
    Burden and temporal trends of female-specific cancers in China: A systematic analysis of the 2023 global burden of disease study.
    PLoS One. 2026;21:e0351539.
    PubMed     Abstract available
    
    
    
33. EZECHUKWU C, Ayandipo EO, Osoteku D, Ibrahim R, et al
    Gaps and barriers preventing sustained delivery of HPV vaccination in Kano, Kaduna, and Lagos states: An exploratory qualitative study.
    PLoS One. 2026;21:e0350510.
    PubMed     Abstract available
    
    
    
34. MUHAMMAD-OLODO AO, Asher L
    Understanding factors influencing HPV vaccine uptake among caregivers in Kwara State, Nigeria: A qualitative study.
    PLoS One. 2026;21:e0351659.
    PubMed     Abstract available
    
    
    
35. NOREEN K, Noor M, Maryam S, Baig M, et al
    From global to local: Developing a context-specific BeSD-HPV tool through cultural and linguistic adaptation in Pakistan.
    PLoS One. 2026;21:e0350162.
    PubMed     Abstract available
    
    
    
36. ILGAZI KILIC E, Kilic S
    Multi-scale feature integration with enhanced cytomorph for high-accuracy cervical cytology classification.
    PLoS One. 2026;21:e0351063.
    PubMed     Abstract available
    
    
    
37. NEEMA UFOY MUNGU Y, Desreux J, Bianchi E, Junior BL, et al
    Human papillomavirus genotypes and factors associated with major cervical smear abnormalities in a sickle cell endemic area of Kisangani, Democratic Republic of the Congo.
    PLoS One. 2026;21:e0350982.
    PubMed     Abstract available
    
    
    
38. EFFAH K, Ametefe DL, Amuah JE, Essel NOM, et al
    A collaborative cervical precancer screening strategy with concurrent HPV genotyping and visual inspection using alumni of a training centre across Ghana: The Rotary 'Protect Your Pearl' initiative.
    PLoS One. 2026;21:e0350573.
    PubMed     Abstract available
    
    
    
39. SEDAGHAT SHAYEGAN G, Salehipour P, Najafi A, Modarressi MH, et al
    Optimizing an ethanol-based fixative for enhanced nucleic acid preservation in cervical samples using a central composite design approach.
    PLoS One. 2026;21:e0349088.
    PubMed     Abstract available
    
    
    
40. KIM HJ, Lee HJ, Shin HY, Lee HS, et al
    Understanding barriers and facilitators to cervical cancer prevention among young Korean Women: A focus group interview study.
    PLoS One. 2026;21:e0353242.
    PubMed     Abstract available
    
    
    
41. BERZA N, Zodzika J, Kivite-Urtane A, Curkste A, et al
    Factors associated with women's choice for mode of cervical sampling in future cervical cancer screening.
    PLoS One. 2026;21:e0353180.
    PubMed     Abstract available
    
    
    
42. YANG S, Hou Y, Wang X, Kang S, et al
    Correction: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis.
    PLoS One. 2026;21:e0353864.
    PubMed     Abstract available
    
    
    
43. ZOUZOULAS D, Sofianou I, Chatzistamatiou K, Theodoulidis V, et al
    Comparison of Moducare versus Wait-and-See approach for histologically proven Low-grade Cervical Intraepithelial Neoplasia (CIN1) (MODUCIN1 TRIAL) - Study protocol.
    PLoS One. 2026;21:e0353119.
    PubMed     Abstract available
    
    
    
44. TAFESE AM, Dirbaba B, Fentie M, Zeigler-Johnson C, et al
    Cervical cancer screening coverage and associated factors among women aged 25-59 in Eswatini: Insights from the 2021 Population-Based HIV Impact Assessment (PHIA).
    PLoS One. 2026;21:e0354508.
    PubMed     Abstract available
    
    
    
45. ZENEBE S, Yeheyis T, Tadesse F, Deribe B, et al
    Perceived facilitators and barriers against human papillomavirus vaccine among rural parents with eligible daughters in the Alle district, Southern Ethiopia.
    PLoS One. 2026;21:e0354372.
    PubMed     Abstract available
    
    
    
46. LONG C, Wang S, Wang Y
    SPP1 promotes cisplatin resistance in cervical cancer by regulating KRAS expression.
    PLoS One. 2026;21:e0353621.
    PubMed     Abstract available
    
    
    
47. JOHN A, Rasheed R, Idikula MJ
    Perceptions and practices among students, parents, and teachers of the Human Papillomavirus (HPV) Vaccination: A pilot feasibility study from Rural Kerala.
    PLoS One. 2026;21:e0340559.
    PubMed     Abstract available
    
    
    
48. YANG H, Tan Y, Pang Y, Chen X, et al
    Efficacy comparison of concurrent chemoradiotherapy alone versus concurrent chemoradiotherapy plus adjuvant chemotherapy in stage III Locally Advanced Cervical Cancer: A single-center, retrospective observational cohort study.
    PLoS One. 2026;21:e0354207.
    PubMed     Abstract available
    
    
    January 2025
49. DE FOUW M, Boere MWM, Nakisige C, Nabwire M, et al
    Cervical cancer care at a tertiary oncology facility in Uganda: Comparing daily practice with national treatment targets on cervical cancer control.
    PLoS One. 2025;20:e0316323.
    PubMed     Abstract available
    
    
    
50. TAKAHASHI Y, Sasamori Y, Higuchi R, Kaku A, et al
    Effects of different educational interventions on cervical cancer knowledge and human papillomavirus vaccination uptake among young women in Japan: Preliminary results of a cluster randomized controlled trial.
    PLoS One. 2025;20:e0311588.
    PubMed     Abstract available
    
    
    
51. KHOMPHAIBOONKIJ U, Sreamsukcharoenchai N, Pitakkarnkul S, Rittiluechai K, et al
    Correction: Knowledge of Thai women in cervical cancer etiology and screening.
    PLoS One. 2025;20:e0318184.
    PubMed     Abstract available
    
    
    
52. ASIRWA FC, Bresnahan BW, Yego F, Duncan D, et al
    A prospective model of the potential clinical and economic impact of cervical cancer screening supported by a mobile phone app.
    PLoS One. 2025;20:e0316001.
    PubMed     Abstract available
    
    
    
53. DEMEKE AD, Deribe B, Girma M, Gizaw M, et al
    Screening attendance of breast or cervical cancers and its associated factors among 30-49 year old women in Gedeo zone, South Ethiopia: Cross-sectional study.
    PLoS One. 2025;20:e0315891.
    PubMed     Abstract available
    
    
    
54. UM S, Sopheab H
    Breast and cervical cancer screening among women at reproductive age in Cambodia: A secondary analysis of Cambodia Demographic and Health Survey 2022.
    PLoS One. 2025;20:e0295881.
    PubMed     Abstract available
    
    
    
55. 
    Retraction: Long Noncoding RNA-EBIC Promotes Tumor Cell Invasion by Binding to EZH2 and Repressing E-Cadherin in Cervical Cancer.
    PLoS One. 2025;20:e0318789.
    PubMed    
    
    
    
56. OPITO R, Tiyo Ayikobua E, Akurut H, Alwedo S, et al
    Factors associated with uptake and acceptability of cervical cancer screening among female sex workers in Northeastern Uganda: A cross-sectional study.
    PLoS One. 2025;20:e0312988.
    PubMed     Abstract available
    
    
    
57. GAO Y, Liang G, Chang C, Pan F, et al
    Analysis of cervical and breast cancer screening behavior and its influencing factors among urban and rural women in Beijing.
    PLoS One. 2025;20:e0316898.
    PubMed     Abstract available
    
    
    
58. WAGNER GJ, Bogart LM, Matovu JKB, Gwokyalya V, et al
    Study protocol for a hybrid implementation-effectiveness trial of Game Changers for Cervical Cancer Prevention in Uganda.
    PLoS One. 2025;20:e0317491.
    PubMed     Abstract available
    
    
    
59. PANERU B, Karmacharya A, Bharati A, Makaju S, et al
    Correction: Association between cancer stigma and cervical cancer screening uptake among women of Dhulikhel and Banepa, Nepal.
    PLoS One. 2025;20:e0318367.
    PubMed     Abstract available
    
    
    
60. AYTAC S, Ozbey G
    Photodiagnosis and photodynamic recognition of cervical cancer with SEM and AFM images.
    PLoS One. 2025;20:e0316544.
    PubMed     Abstract available
    
    
    
61. HAMZA MN, Tariqul Islam M, Lavadiya S, Ud Din I, et al
    Design and validation of ultra-compact metamaterial-based biosensor for non-invasive cervical cancer diagnosis in terahertz regime.
    PLoS One. 2025;20:e0311431.
    PubMed     Abstract available
    
    
    
62. MALOBA M, Finocchario-Kessler S, Wexler C, Staggs V, et al
    The Cancer Tracking System (CATSystem): Study protocol of a randomized control trial to evaluate a systems level intervention for cervical cancer screening, treatment, referral and follow up in Kenya.
    PLoS One. 2025;20:e0318941.
    PubMed     Abstract available
    
    
    
63. REMMEL ML, Suija K, Markina A, Tisler A, et al
    Navigating the risks: Stakeholder views on risk-based cervical cancer screening.
    PLoS One. 2025;20:e0317986.
    PubMed     Abstract available
    
    
    
64. ASIIMWE S, Bagenda FN, Mugisa T
    Factors associated with uptake of human papilloma virus vaccine among adolescent girls: A cross sectional survey on insights into HPV Infection Prevention in Kabarole District, Western Uganda.
    PLoS One. 2025;20:e0306960.
    PubMed     Abstract available
    
    
    
65. ETEMADIFAR M, Shoeib S, Salari M, Etemadifar M, et al
    Gynecologic health of women with multiple sclerosis: An overview on the current status and findings of Pap tests in a low-income setting.
    PLoS One. 2025;20:e0320069.
    PubMed     Abstract available
    
    
    
66. KIDAYA BN, Mwanga JR, Muhini OO, Mwaisungu HM, et al
    Healthcare-seeking behaviors and factors influencing non-adherence among cervical cancer patients attending Bugando Oncology Clinic in Mwanza, Tanzania: A qualitative Phenomenological study.
    PLoS One. 2025;20:e0317609.
    PubMed     Abstract available
    
    
    
67. XIE R, Xie K, Lin X, Ji Y, et al
    A Comparison of neoadjuvant chemotherapy and concurrent chemoradiotherapy for for FIGO 2018 stage IB3/IIA2 Cervical squamous cell carcinoma: Long-term efficacy and safety in a resource-limited setting.
    PLoS One. 2025;20:e0319405.
    PubMed     Abstract available
    
    
    
68. BURKE-GARCIA A, Cutroneo E, Afanaseva D, Madden K, et al
    Findings from a qualitative analysis: Social media influencers of color as trusted messengers of HPV vaccination messages.
    PLoS One. 2025;20:e0319160.
    PubMed     Abstract available
    
    
    
69. MAFI S, Theuillon F, Meyer S, Woillard JB, et al
    Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples.
    PLoS One. 2025;20:e0320978.
    PubMed     Abstract available
    
    
    
70. AVILA E, Hernandez-Monterde LD, Cedro-Tanda A, Lizardi-Aguilera TM, et al
    Transcriptomic profile induced by calcitriol in CaSki human cervical cancer cell line.
    PLoS One. 2025;20:e0319812.
    PubMed     Abstract available
    
    
    
71. WANG G, Jia C, Wang D, Liang L, et al
    Scutellaria Barbata inhibits epithelial-mesenchymal transformation through PI3K/AKT and MDM2 thus inhibiting the proliferation, migration and promoting apoptosis of Cervical Cancer cells.
    PLoS One. 2025;20:e0321556.
    PubMed     Abstract available
    
    
    
72. ABATE A, Munshea A, Nibret E, Bezabih B, et al
    Evaluation of Onco E6 point of care rapid diagnostic test for human papilloma virus in Bahir Dar, Amhara Regional State, Ethiopia.
    PLoS One. 2025;20:e0321076.
    PubMed     Abstract available
    
    
    
73. BAASLAND I, Bjorge T, Engesaeter B, Trope A, et al
    Cervical intraepithelial neoplasia grade 1 and long-term risk of progression and treatment.
    PLoS One. 2025;20:e0320739.
    PubMed     Abstract available
    
    
    
74. MELAKU A, Abebe SN, Haile S
    Utilization of screening services on cervical cancer and associated factors among female health workers in Addis Ababa, Ethiopia.
    PLoS One. 2025;20:e0321662.
    PubMed     Abstract available
    
    
    
75. ZHOU Q, Song B, He Y, Zhang Z, et al
    Identification of a disulfidptosis-related genes signature for diagnostic and immune infiltration characteristics in cervical cancer.
    PLoS One. 2025;20:e0322387.
    PubMed     Abstract available
    
    
    
76. RAPAJIC-MORAN I, Filipic B, Rajkovic D, Rakic M, et al
    Strengthening the role of community pharmacy in HPV vaccination roll-out in Serbia at national and local levels: A pharmacy-based education approach.
    PLoS One. 2025;20:e0322584.
    PubMed     Abstract available
    
    
    
77. NOREEN K, Khalid SN, Javaid M, Khan SA, et al
    Public Health Implications of Introducing Human Papillomavirus (HPV) Vaccination in Pakistan: A protocol for a mixed-method study to explore community perceptions and health system preparedness.
    PLoS One. 2025;20:e0323826.
    PubMed     Abstract available
    
    
    
78. ZARGARAN H, Ghaemi A, Shenagari M, Samadi M, et al
    Boosting immune response against cervical cancer: A combined approach using oncolytic virus and targeted therapies.
    PLoS One. 2025;20:e0312979.
    PubMed     Abstract available
    
    
    
79. DANIELS J, Kyei KA, Frimpong-Boateng PD, Nyantakyi AY, et al
    Sexual function outcomes in prostate and cervical cancer patients treated with radiotherapy in sub-Saharan Africa: A cross-sectional study.
    PLoS One. 2025;20:e0324662.
    PubMed     Abstract available
    
    
    
80. CASTELLANO T, ElHabr AK, Washington C, Ting J, et al
    Correction: Health disparities in cervical cancer: Estimating geographic variations of disease burden and association with key socioeconomic and demographic factors in the US.
    PLoS One. 2025;20:e0324971.
    PubMed     Abstract available
    
    
    
81. GOVINDSAMY K, Noll S, Blose N, Amponsah-Dacosta E, et al
    Effectiveness of integrating cervical cancer prevention strategies into HIV care programmes: A mixed-methods systematic review protocol.
    PLoS One. 2025;20:e0306496.
    PubMed     Abstract available
    
    
    
82. SHI Y, Zhang L, Zhou Y, Liao X, et al
    A cross-sectional study of factors influencing sexual health among spouses of patients with cervical cancer.
    PLoS One. 2025;20:e0322141.
    PubMed     Abstract available
    
    
    
83. ILIC I, Babic G, Sipetic Grujicic S, Zivanovic Macuzic I, et al
    Validity of the process and outcome specific measure in women with abnormal Papanicolaou screening test.
    PLoS One. 2025;20:e0325131.
    PubMed     Abstract available
    
    
    
84. ELBASYOUNI A, Kyama MC, El-Shemy HA, Mwitari PG, et al
    Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer.
    PLoS One. 2025;20:e0323680.
    PubMed     Abstract available
    
    
    
85. ENYEW EB, Kasaye MD, Kebede SD, Feyisa MS, et al
    Human Papillomavirus Vaccination uptake and associated factors among schools girls aged between 9-14 years in Ethiopia: Performance Monitoring for Action (PMA-ET) 2023, multilevel analysis.
    PLoS One. 2025;20:e0325557.
    PubMed     Abstract available
    
    
    
86. ISLAM T, Khan MAS, Hawlader MDH, Meem NE, et al
    Awareness about cervical cancer and its socio-economic determinants among adults in Bangladesh: Results from a nationwide cross-sectional study.
    PLoS One. 2025;20:e0325712.
    PubMed     Abstract available
    
    
    
87. SHAN Y, Abulikemu G, Liu L, Zhang Y, et al
    Risk factors associated with adverse outcomes after cervical conization in patients with cervical adenocarcinoma in situ.
    PLoS One. 2025;20:e0325748.
    PubMed     Abstract available
    
    
    
88. YANG Y, Lu Y, Li Y, Qin C, et al
    Factors affecting caregivers' HPV vaccination decisions for adolescent girls: A secondary analysis of a Chinese RCT.
    PLoS One. 2025;20:e0324260.
    PubMed     Abstract available
    
    
    
89. PATURY P, Russomano FB, Moreira MAM, Kappaun NRC, et al
    Associations between genetic HPV 16 diversity and cervical cancer prognosis.
    PLoS One. 2025;20:e0308895.
    PubMed     Abstract available
    
    
    
90. ARRIVILLAGA M, Torres MDM, Neira D, Garcia-Cifuentes JP, et al
    Patient acceptability of CITOBOT for cervical cancer screening: A mixed-method study.
    PLoS One. 2025;20:e0325805.
    PubMed     Abstract available
    
    
    
91. RANA T, Chan DNS, Law BMH, Choi KC, et al
    Determinants of cervical cancer screening utilisation among women in the least developed countries: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0321627.
    PubMed     Abstract available
    
    
    
92. YAO Y, Chen Y, Yang A, Ye Y, et al
    MVT-Net: A novel cervical tumour segmentation using multi-view feature transfer learning.
    PLoS One. 2025;20:e0325424.
    PubMed     Abstract available
    
    
    
93. NDJENGUE BENGONE BC, Toniolo J, Filankembo Kava AC, Ngoungou EB, et al
    Psychological repercussions of breast or uterine cervical cancer disclosure to women in Gabon.
    PLoS One. 2025;20:e0326378.
    PubMed     Abstract available
    
    
    
94. HASAN MM, Islam MH
    Herd immunity and prevention in HPV transmission with exogenous reinfection.
    PLoS One. 2025;20:e0327233.
    PubMed     Abstract available
    
    
    
95. MREMI A, Joseph AP, Njunwa DV, Ntupwa DA, et al
    Knowledge, attitude and practices towards cervical cancer control among University students in Kilimanjaro region, Tanzania.
    PLoS One. 2025;20:e0327879.
    PubMed     Abstract available
    
    
    
96. AGHA S, Nsofor I
    HPV vaccine uptake among adolescent girls in Nigeria: The complex role of caregivers' education.
    PLoS One. 2025;20:e0325684.
    PubMed     Abstract available
    
    
    
97. LIU Q, Peng Y, Liu W, Luo X, et al
    SERPINH1 functions as a multifunctional regulator to promote the malignant progression of cervical cancer.
    PLoS One. 2025;20:e0329007.
    PubMed     Abstract available
    
    
    
98. MENGISTIE BA, Melese M, Gebiru AM, Getnet M, et al
    Uptake of cervical cancer screening and its determinants in Africa: Umbrella review.
    PLoS One. 2025;20:e0328103.
    PubMed     Abstract available
    
    
    
99. MREMA A, Ngoma M, Lugina EL, Kahakwa A, et al
    Genotype distribution of human papillomavirus among women with cervical cancer stratified by HIV status in Tanzania.
    PLoS One. 2025;20:e0322311.
    PubMed     Abstract available
    
    
    
100. KHATRI RB, Endalamaw A, Darssan D, Assefa Y, et al
     A scoping review of the levels, implementation strategies, enablers, and barriers to cervical, breast, and colorectal cancer screening among migrant populations in selected English-speaking high-income countries.
     PLoS One. 2025;20:e0329854.
     PubMed     Abstract available
     
     
     
101. KASSA B, Mohammed A, Wassie GT
     Parents' acceptance of human papilloma virus vaccination for their daughters in adet town, North Gojjam zone, Northwest Ethiopia: A mixed method study.
     PLoS One. 2025;20:e0330911.
     PubMed     Abstract available
     
     
     
102. DEN'O ZD, Paulos W, Markos D, Oche WO, et al
     Human papilloma virus vaccination uptake and associated factors among adolescent girls in Merab Abaya district, Gamo zone, Southern Ethiopia: Mixed methods.
     PLoS One. 2025;20:e0330760.
     PubMed     Abstract available
     
     
     
103. BULAMBA RM, Kyasanku E, Nalugoda F, Daama A, et al
     Assessing Knowledge, Uptake and Factors associated with cervical cancer screening among women in selected communities of Wakiso district in Uganda: A population-based study.
     PLoS One. 2025;20:e0317641.
     PubMed     Abstract available
     
     
     
104. OLUBODUN T, Olaniran A, Awowole IO, Ohazurike E, et al
     Practice of opportunistic cervical cancer screening and health education among health workers in Ogun State, Nigeria: A qualitative study of barriers and facilitators.
     PLoS One. 2025;20:e0316883.
     PubMed     Abstract available
     
     
     
105. MWANGI JH, Mbeje PN, Mtshali GN
     Exploring the roles of male partners in the transmission, prevention and control of cervical cancer in Central Kenya: A qualitative study.
     PLoS One. 2025;20:e0324575.
     PubMed     Abstract available
     
     
     
106. JAFRIN S, Aziz MA, Barek MA, Reza MS, et al
     Association of missense variant DCLRE1B rs3761936 with breast and cervical cancer risk-A case-control study.
     PLoS One. 2025;20:e0331492.
     PubMed     Abstract available
     
     
     
107. WYNN A, Harris D, Modest A, Reyes MF, et al
     Short-term costs and cost-efficiency of HPV triage strategies in a high HIV-prevalence setting: Evidence from Botswana.
     PLoS One. 2025;20:e0328803.
     PubMed     Abstract available
     
     
     
108. KHIRUDDIN K, Mustafa WA, Islam MA, Jamaludin KR, et al
     Comparative analysis of cervical cancer classification of DPAGCHE-enhanced Pap smear images using convolutional neural network models.
     PLoS One. 2025;20:e0330103.
     PubMed     Abstract available
     
     
     
109. CHEN D, Wu H, Huang F, Tan K, et al
     Prognostic follow-up of high-grade squamous intraepithelial lesions of the cervix near the conization margin: A retrospective cohort study.
     PLoS One. 2025;20:e0331184.
     PubMed     Abstract available
     
     
     
110. BASHORUN AO, Kotei L, Jallow AF, Jawla O, et al
     Human papillomavirus, sexually transmitted infections, and antimicrobial resistance in West Africa: Estimating population burden and understanding exposures to accelerate vaccine impact and drive new interventions: The PHASE survey protocol.
     PLoS One. 2025;20:e0332842.
     PubMed     Abstract available
     
     
     
111. MURENZI G, Kanyabwisha F, Demarco M, Muhoza B, et al
     Determinants of cervical high-risk human papillomavirus positivity among Rwandan women living with human immunodeficiency virus.
     PLoS One. 2025;20:e0333077.
     PubMed     Abstract available
     
     
     
112. KAMAU SW, Jepkorir M, Kipkoech G, Lagu IJL, et al
     Antiproliferative activity of Grewia villosa ethyl acetate extract on cervical cancer HeLa cell line: Mechanistic insights through network pharmacology and functional assays approach.
     PLoS One. 2025;20:e0331649.
     PubMed     Abstract available
     
     
     
113. ADISU MA, Habtie TE, Kitaw TA, Gessesse AD, et al
     The rising burden of female cancer in Ethiopia (2000-2021) and projections to 2040: Insights from the global burden of disease study.
     PLoS One. 2025;20:e0333787.
     PubMed     Abstract available
     
     
     
114. ZHANG Z, Li Y, Huang H, Wei T, et al
     Disparities and trends of the incidence and mortality of female-specific cancers in the United States.
     PLoS One. 2025;20:e0334128.
     PubMed     Abstract available
     
     
     
115. CHOU HH, Chu PY, Wu YH, Feng C, et al
     Health impact and cost-effectiveness analysis of gender-neutral versus female-only 9-valent human papillomavirus vaccination in Taiwan.
     PLoS One. 2025;20:e0333757.
     PubMed     Abstract available
     
     
     
116. LARSSON GL, Carlsson J, Helenius G, Bergengren L, et al
     Molecular triage on HPV-positive samples in a cervical screening setting.
     PLoS One. 2025;20:e0333539.
     PubMed     Abstract available
     
     
     
117. YANG S, Liu L, Su Q, Wang J, et al
     Construction of a prognostic prediction model for concurrent radiotherapy in cervical cancer using GEO and TCGA databases with preliminary validation analysis.
     PLoS One. 2025;20:e0334281.
     PubMed     Abstract available
     
     
     
118. SHIN HJ, Joo J, Yoon JH, Yoo CW, et al
     Correction: Physical Status of Human Papillomavirus Integration in Cervical Cancer Is Associated with Treatment Outcome of the Patients Treated with Radiotherapy.
     PLoS One. 2025;20:e0335489.
     PubMed     Abstract available
     
     
     
119. YOUNAS S, Malik ZI, Khan MU, Manzoor S, et al
     Identification of novel therapeutic inhibitors against E6 and E7 oncogenes of HPV-16 associated with cervical cancer.
     PLoS One. 2025;20:e0323595.
     PubMed     Abstract available
     
     
     
120. BEN TAHER Y, Ben Rekaya M, Romdhane E, Miladi B, et al
     HPV testing in cervical cancer formalin-fixed paraffin embedded tissues: Reliability of the Xpert HPV test and high-risk HPV genotypes distribution in Tunisia.
     PLoS One. 2025;20:e0333600.
     PubMed     Abstract available
     
     
     
121. ORENGO JC, Bierrenbach AL, Aranda Flores CE, Lopez ED, et al
     Trends in the burden of HPV-associated cancers in Mexico: An analysis from 2011 to 2019.
     PLoS One. 2025;20:e0335307.
     PubMed     Abstract available
     
     
     
122. CHEN J, Hong J, Chen K, Zhang X, et al
     Dosimetric divergence in ICBT vs. IC/ISBT configurations: Comparative analysis of three optimization algorithms for cervical cancer brachytherapy.
     PLoS One. 2025;20:e0335405.
     PubMed     Abstract available
     
     
     
123. DONKOH ET, Abdul IW, Ahiakpa AK, Williams I, et al
     Protocol for a systematic review and meta-analysis of the impact of cervical cancer prevention initiatives in Ghana.
     PLoS One. 2025;20:e0337011.
     PubMed     Abstract available
     
     
     
124. HALVORSON-FRIED SM, Higgins ICA, Gilkey MB, Lazard AJ, et al
     Perceived effectiveness of messages to address cervical cancer screening barriers: An online experiment.
     PLoS One. 2025;20:e0336693.
     PubMed     Abstract available
     
     
     
125. HAN T, Deng S
     Prevalence and genotype distribution of Human Papillomavirus (HPV) among 14,110 women in Anqing urban area: A population-based cross-sectional survey.
     PLoS One. 2025;20:e0336959.
     PubMed     Abstract available
     
     
     
126. MENGISTIE BA, Aragaw GM, Anteneh TA, Wondie KY, et al
     Prevalence and determinants of precancerous cervical lesions among women screened for cervical cancer in Africa: A systematic review and meta-analysis.
     PLoS One. 2025;20:e0338484.
     PubMed     Abstract available
     
     
     
127. NESSA A, Ferdouse J, Khatoon F, Sonia AA, et al
     High-risk human papillomavirus genotypes among women of hill districts in Bangladesh.
     PLoS One. 2025;20:e0338092.
     PubMed     Abstract available
     
     
     
128. YAN Z, Guo C, Liu Y, Li J, et al
     From cervix to multisite: Detection of lower genital tract lesions in a 10-year cross-sectional colposcopy clinic study.
     PLoS One. 2025;20:e0338489.
     PubMed     Abstract available
     
     
     
129. HOQUE R, Cirovic S, Hughes MP, Labeed FH, et al
     Electrophysiological fingerprints of healthy cervical epithelial and HeLa cells: Membrane potential, zeta potential and passive electrical properties.
     PLoS One. 2025;20:e0337538.
     PubMed     Abstract available
     
     
     January 2024
130. ALJREES T
     Improving prediction of cervical cancer using KNN imputer and multi-model ensemble learning.
     PLoS One. 2024;19:e0295632.
     PubMed     Abstract available
     
     
     
131. MUNSHI RM
     Novel ensemble learning approach with SVM-imputed ADASYN features for enhanced cervical cancer prediction.
     PLoS One. 2024;19:e0296107.
     PubMed     Abstract available
     
     
     
132. YU C, Wu X, Zhang S, Zhang L, et al
     Prognostic model for survival in patients with neuroendocrine carcinomas of the cervix: SEER database analysis and a single-center retrospective study.
     PLoS One. 2024;19:e0296446.
     PubMed     Abstract available
     
     
     
133. GUILLAUME D, Waheed DE, Schleiff M, Muralidharan KK, et al
     Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries.
     PLoS One. 2024;19:e0291990.
     PubMed     Abstract available
     
     
     
134. SARMIENTO-MEDINA MI, de Amaya MP, Villamizar-Gomez L, Gonzalez-Coba AC, et al
     High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study.
     PLoS One. 2024;19:e0297579.
     PubMed     Abstract available
     
     
     
135. KANG SW, Kang OJ, Lee JY, Kim H, et al
     Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer.
     PLoS One. 2024;19:e0298815.
     PubMed     Abstract available
     
     
     
136. MANGENAH C, Sibanda EL, Maringwa G, Sithole J, et al
     Provider and female client economic costs of integrated sexual and reproductive health and HIV services in Zimbabwe.
     PLoS One. 2024;19:e0291082.
     PubMed     Abstract available
     
     
     
137. MUNSHI RM
     Correction: Novel ensemble learning approach with SVM-imputed ADASYN features for enhanced cervical cancer prediction.
     PLoS One. 2024;19:e0298980.
     PubMed     Abstract available
     
     
     
138. VARON ML, Geng Y, Fellman BM, Troisi C, et al
     Interventions to increase follow-up of abnormal cervical cancer screening results: A systematic literature review and meta-analysis.
     PLoS One. 2024;19:e0291931.
     PubMed     Abstract available
     
     
     
139. YAO B, Peng J, Song W, Yang L, et al
     Real-world effectiveness of cytology and HPV-based screening strategy in cervical cancer screening: A cross-sectional population-based study in Chengdu, China.
     PLoS One. 2024;19:e0299651.
     PubMed     Abstract available
     
     
     
140. SUN J, Frick KD, Liang H, Chow CM, et al
     Examining cancer screening disparities by race/ethnicity and insurance groups: A comparison of 2008 and 2018 National Health Interview Survey (NHIS) data in the United States.
     PLoS One. 2024;19:e0290105.
     PubMed     Abstract available
     
     
     
141. ZHANG J, Yuan J, Zhang D, Yang Y, et al
     Short video platforms as sources of health information about cervical cancer: A content and quality analysis.
     PLoS One. 2024;19:e0300180.
     PubMed     Abstract available
     
     
     
142. CAROZZI FM, Royder Yanez R, Paganini I, Sani C, et al
     Cervical cancer prevention: Feasibility of self-sampling and HPV testing in rural and urban areas of Bolivia: An observational study.
     PLoS One. 2024;19:e0292605.
     PubMed     Abstract available
     
     
     
143. LIU Z, Fan T, Mo X, Kan J, et al
     Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
     PLoS One. 2024;19:e0298271.
     PubMed     Abstract available
     
     
     
144. LIN Y, Long Y, He J, Yi Q, et al
     The residual rate of HPV and the recurrence rate of CIN after LEEP with negative margins: A meta-analysis.
     PLoS One. 2024;19:e0298520.
     PubMed     Abstract available
     
     
     
145. OOMMEN AM, Isaac R, Paul B, Weller D, et al
     Strategies for primary HPV test-based cervical cancer screening programme in resource-limited settings in India: Results from a quasi-experimental pragmatic implementation trial.
     PLoS One. 2024;19:e0301385.
     PubMed     Abstract available
     
     
     
146. LEMLEM SB, Gary RA, Yeager KA, Sisay MM, et al
     Psychometric properties of a modified health belief model for cervical cancer and visual inspection with acetic acid among healthcare professionals in Ethiopia.
     PLoS One. 2024;19:e0295905.
     PubMed     Abstract available
     
     
     
147. KHUMALO PG, Carey M, Mackenzie L, Sanson-Fisher R, et al
     Cervical cancer screening knowledge and associated factors among Eswatini women: A cross-sectional study.
     PLoS One. 2024;19:e0300763.
     PubMed     Abstract available
     
     
     
148. DUA R, Bhardwaj T, Ahmad I, Somvanshi P, et al
     Investigating the potential of Juglans regia phytoconstituents for the treatment of cervical cancer utilizing network biology and molecular docking approach.
     PLoS One. 2024;19:e0287864.
     PubMed     Abstract available
     
     
     
149. ZEBER-LUBECKA N, Kulecka M, Dabrowska M, Baginska-Drabiuk K, et al
     Cervical microbiota dysbiosis associated with high-risk Human Papillomavirus infection.
     PLoS One. 2024;19:e0302270.
     PubMed     Abstract available
     
     
     
150. XU F, Carlson SA, Greenlund KJ
     Understanding primary care providers' attitudes towards preventive screenings to patients with inflammatory bowel disease.
     PLoS One. 2024;19:e0299890.
     PubMed     Abstract available
     
     
     
151. MOSHI JM, Ummelen M, Smedts F, Ramaekers FCS, et al
     Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix.
     PLoS One. 2024;19:e0297008.
     PubMed     Abstract available
     
     
     
152. TIRKASO BH, Bayisa TH, Desta TW
     Histopathologic patterns and factors associated with cervical lesions at Jimma Medical Center, Jimma, Southwest Ethiopia: A two-year cross-sectional study.
     PLoS One. 2024;19:e0301559.
     PubMed     Abstract available
     
     
     
153. WANG QL, Gong C, Meng XY, Fu M, et al
     TPP1 is associated with risk of advanced precursors and cervical cancer survival.
     PLoS One. 2024;19:e0298118.
     PubMed     Abstract available
     
     
     
154. SHIMELS T, Gashawbeza B, Fenta TG
     Validation of the Amharic version of perceived access to healthcare services for patients with cervical cancer in Ethiopia: A second-order confirmatory factor analysis.
     PLoS One. 2024;19:e0300815.
     PubMed     Abstract available
     
     
     
155. ILIKA CP, Eleje GU, Chiemeka ME, Ilika FN, et al
     Effects of speculum lubrication on cervical smears for cervical cancer screening: A double blind randomized clinical trial.
     PLoS One. 2024;19:e0292207.
     PubMed     Abstract available
     
     
     
156. BROSHKEVITCH CJ, Barnabas RV, Liu G, Palanee-Phillips T, et al
     Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
     PLoS One. 2024;19:e0301997.
     PubMed     Abstract available
     
     
     
157. HUSSEIN K, Kokwaro G, Wafula F, Kassie GM, et al
     Assessing the influence of the health system on access to cervical cancer prevention, screening, and treatment services at public health centers in Addis Ababa, Ethiopia.
     PLoS One. 2024;19:e0300152.
     PubMed     Abstract available
     
     
     
158. AGYARE GYANE F, Modey E, Maya E, Bonney EY, et al
     Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana.
     PLoS One. 2024;19:e0303535.
     PubMed     Abstract available
     
     
     
159. KIM JY, Jung JH, Jung S, Lee S, et al
     Glyoxalase 1: Emerging biomarker and therapeutic target in cervical cancer progression.
     PLoS One. 2024;19:e0299345.
     PubMed     Abstract available
     
     
     
160. WANG Q, Xu M, Zhou H, Li Y, et al
     Prevalence characteristics of cervical human papillomavirus infection in Chengdu and Aba District, Sichuan Province, China.
     PLoS One. 2024;19:e0304760.
     PubMed     Abstract available
     
     
     
161. TONG Y, Jia L, Li M, Li H, et al
     Identification of exosomal circSLC26A4 as a liquid biopsy marker for cervical cancer.
     PLoS One. 2024;19:e0305050.
     PubMed     Abstract available
     
     
     
162. TSIMA BM, Motlhatlhedi K, Sharma K, Rantshabeng P, et al
     The association between smoking and cervical human papillomavirus infection among women from indigenous communities in western Botswana.
     PLoS One. 2024;19:e0302153.
     PubMed     Abstract available
     
     
     
163. NONBOE MH, Napolitano GM, Kann C, Andersen B, et al
     Screening outcome of HPV-vaccinated women: Data from the Danish Trial23 cohort study.
     PLoS One. 2024;19:e0306044.
     PubMed     Abstract available
     
     
     
164. GONG S, Li G, Li D, Liu Y, et al
     The risk for subsequent primary lung cancer after cervical carcinoma: A quantitative analysis based on 864,627 cases.
     PLoS One. 2024;19:e0305670.
     PubMed     Abstract available
     
     
     
165. QI J, Li J, Zhu X, Zhao S, et al
     Endothelial cell specific molecule 1 promotes epithelial-mesenchymal transition of cervical cancer via the E-box binding homeobox 1.
     PLoS One. 2024;19:e0304597.
     PubMed     Abstract available
     
     
     
166. JIN S, Lin F, Yang L, Zhang Q, et al
     Association between dietary folate intake and HPV infection: NHANES 2005-2016.
     PLoS One. 2024;19:e0306636.
     PubMed     Abstract available
     
     
     
167. CASTELLANO T, ElHabr AK, Washington C, Ting J, et al
     Health disparities in cervical cancer: Estimating geographic variations of disease burden and association with key socioeconomic and demographic factors in the US.
     PLoS One. 2024;19:e0307282.
     PubMed     Abstract available
     
     
     
168. BALQIS-ALI NZ, Anis-Syakira J, Fun WH, Mohd Said Z, et al
     Achieving cervical cancer elimination: The simulated impacts of HPV vaccination and transitioning from liquid-based cytology to HPV-based screening test.
     PLoS One. 2024;19:e0307880.
     PubMed     Abstract available
     
     
     
169. 
     Retraction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis.
     PLoS One. 2024;19:e0308113.
     PubMed    
     
     
     
170. MUCHAILI L, Simushi P, Mweene BC, Mwakyoma T, et al
     Prevalence and correlates of Human Papillomavirus infection in females from Southern Province, Zambia: A cross-sectional study.
     PLoS One. 2024;19:e0299963.
     PubMed     Abstract available
     
     
     
171. LORDELO MV, Oliveira CZ, Aguirre Buexm L, Vieira Reis RM, et al
     Randomized experimental population-based study to evaluate the acceptance and completion of and preferences for cervical cancer screening.
     PLoS One. 2024;19:e0306130.
     PubMed     Abstract available
     
     
     
172. NAZRUL N, de Fouw M, Beltman JJ, de Zeeuw J, et al
     Understanding cervical cancer awareness in hard-to-reach areas of Bangladesh: A cross-sectional study involving women and household decisionmakers.
     PLoS One. 2024;19:e0304396.
     PubMed     Abstract available
     
     
     
173. GOLALIPOUR A, Mohammadi A, Hosseinzadeh S, Soltani A, et al
     Synergistic cytotoxicity of olive leaf extract-loaded lipid nanocarriers combined with Newcastle disease virus against cervical cancer cells.
     PLoS One. 2024;19:e0308599.
     PubMed     Abstract available
     
     
     
174. HARIPRASAD R, Bagepally BS, Kumar S, Pradhan S, et al
     Cost-utility analysis of primary HPV testing through home-based self-sampling in comparison to visual inspection using acetic acid for cervical cancer screening in East district, Sikkim, India, 2023.
     PLoS One. 2024;19:e0300556.
     PubMed     Abstract available
     
     
     
175. GOMES FC, Galhardo DDR, Navegante ACG, Santos GSD, et al
     Bioinformatics analysis to identify the relationship between human papillomavirus-associated cervical cancer, toll-like receptors and exomes: A genetic epidemiology study.
     PLoS One. 2024;19:e0305760.
     PubMed     Abstract available
     
     
     
176. ROMLI R, Mohamad EMW, Abd Rahman R, Chew KT, et al
     Validation and usability of SeDAR e-health video for enhancing cervical cancer screening.
     PLoS One. 2024;19:e0310555.
     PubMed     Abstract available
     
     
     
177. ROBLEDO-CADENA DX, Pacheco-Velazquez SC, Vargas-Navarro JL, Padilla-Flores JA, et al
     Synergistic celecoxib and dimethyl-celecoxib combinations block cervix cancer growth through multiple mechanisms.
     PLoS One. 2024;19:e0308233.
     PubMed     Abstract available
     
     
     
178. DANTAS DM, de Souza ATB, de Araujo Santos Camargo JD, Costa APF, et al
     Efficacy and safety of pembrolizumab in cervical cancer: Protocol for systematic review and meta-analysis of randomized clinical trials.
     PLoS One. 2024;19:e0312004.
     PubMed     Abstract available
     
     
     
179. TWABI HH, Msosa TC, Meja SJ, Mukoka M, et al
     Spatial distribution and characteristics of women reporting cervical cancer screening in Malawi: An analysis of the 2020 to 2021 Malawi Population-based HIV Impact Assessment survey data.
     PLoS One. 2024;19:e0309053.
     PubMed     Abstract available
     
     
     
180. SUTHERLAND EK, Smith JD, Ofori-Boateng M, Kushitor SB, et al
     Study protocol for the development of a real-time interface showing the availability of breast and cervical cancer services in Ghana.
     PLoS One. 2024;19:e0312150.
     PubMed     Abstract available
     
     
     
181. RONG Y, Yang Y, Zhang X, Zhou X, et al
     Pain scores reduction with the use of ultrasound-guided paracervical nerve block in patients with cervical cancer undergoing intracavitary brachytherapy: A randomized controlled trial.
     PLoS One. 2024;19:e0310238.
     PubMed     Abstract available
     
     
     
182. SULTANOV M, Koot JAR, de Bock GH, Greuter MJW, et al
     High-risk human papillomavirus testing for cervical cancer screening in Uganda: Considering potential harms and benefits in a low-resource setting.
     PLoS One. 2024;19:e0312295.
     PubMed     Abstract available
     
     
     
183. LAHOLE BK, Woldamlak M, Kussia W
     Determinants of cervical cancer screening intention among reproductive age women in Ethiopia: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0312449.
     PubMed     Abstract available
     
     
     
184. ILIC I, Babic G, Dimitrijevic A, Grujicic SS, et al
     Detecting the impact of diagnostic procedures in Pap-positive women on anxiety using artificial neural networks.
     PLoS One. 2024;19:e0312870.
     PubMed     Abstract available
     
     
     
185. BIRARA M, Urgie T, Sium AF
     Locally advanced cervical cancer: Neoadjuvant chemotherapy plus radical surgery an alternative approach to chemo-radiation in a low-income setting: A descriptive study.
     PLoS One. 2024;19:e0310457.
     PubMed     Abstract available
     
     
     
186. CAMPUZANO TMF, Borba MACSM, de Mendonca Batista P, Nadalin M, et al
     Real world data on cervical cancer treatment patterns, healthcare access and resource utilization in the Brazilian public healthcare system.
     PLoS One. 2024;19:e0312757.
     PubMed     Abstract available
     
     
     
187. AREVALOS A, Valenzuela A, Mongelos P, Barrios H, et al
     Genital infections in high-risk human papillomavirus positive Paraguayan women aged 30-64 with and without cervical lesions.
     PLoS One. 2024;19:e0312947.
     PubMed     Abstract available
     
     
     
188. BAWALLE AA, Nguyen TXT, Khan MSR, Kadoya Y, et al
     Impact of financial literacy and education on breast and cervical cancer screening participation in Japan.
     PLoS One. 2024;19:e0313687.
     PubMed     Abstract available
     
     
     
189. PLISKO O, Zodzika J, Jermakova I, Pcolkina K, et al
     Prediction of high-grade cervical precancerous abnormalities: The role of personal factors, vaginal microflora, sexually transmitted infections, and high-risk human papillomavirus.
     PLoS One. 2024;19:e0313004.
     PubMed     Abstract available
     
     
     
190. ABDULL RAHIM U, Mustapa M, Mohamed Shakrin NNS, Nurdin A, et al
     Current evidence and future direction on evaluating the anticancer effects of curcumin, gingerols, and shogaols in cervical cancer: A systematic review.
     PLoS One. 2024;19:e0314280.
     PubMed     Abstract available
     
     
     
191. DANIELS V, Saxena K, Patterson-Lomba O, Gomez-Lievano A, et al
     Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination program in adolescents in low/middle-income countries: An analysis of Indonesia.
     PLoS One. 2024;19:e0310591.
     PubMed     Abstract available
     
     
     
192. OWARE J, Iddrisu M, Konlan KD, Dzansi G, et al
     Personal and workplace factors influencing the resilience of nurses caring for women with cervical cancer in a resource-constrained setting in Ghana.
     PLoS One. 2024;19:e0314764.
     PubMed     Abstract available
     
     
     
193. WANG J, Lu Y, Li F, Yao D, et al
     Preserving circumflex iliac lymph nodes to reduce the incidence of lower limb lymphedema following lymphadenectomy in cervical and endometrial cancers: A prospective randomized controlled trial.
     PLoS One. 2024;19:e0311144.
     PubMed     Abstract available
     
     
     
194. ASGEDOM YS, Hailegebireal AH, Woldegeorgis BZ, Koyira MM, et al
     Towards 90-70-90 targets: Individual and community level factors associated with cervical cancer screening among women of reproductive age in Tanzania: A multi-level analysis based on 2022 Tanzania demographic and health survey.
     PLoS One. 2024;19:e0315438.
     PubMed     Abstract available
     
     
     
195. CHAKRABORTY S, Nessa A, Ferdous NE, Rahman MM, et al
     Prevalence and genotypic distribution of high-risk human papillomavirus (HPV) among ever-married women in coastal regions of Bangladesh.
     PLoS One. 2024;19:e0313396.
     PubMed     Abstract available
     
     
     
196. LIM C, Seo YJ, Lee JY, Jung ES, et al
     Evaluation of the cervical liquid-based cytology sample as a microbiome resource for dual diagnosis.
     PLoS One. 2024;19:e0308985.
     PubMed     Abstract available
     
     
     
197. CAO Q, Hou Y, Wang C, Yin J, et al
     Effect of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0312128.
     PubMed     Abstract available
     
     
     
198. BHENGU P, Ndwandwe D, Cooper S, Katoto PDMC, et al
     Behavioural and social drivers of human papillomavirus vaccination in eThekwini District of KwaZulu-Natal Province, South Africa.
     PLoS One. 2024;19:e0311509.
     PubMed     Abstract available
     
     
     
199. OHYA A, Miyamoto T, Ichinohe F, Kobara H, et al
     Problems of magnetic resonance diagnosis for gastric-type mucin-positive cervical lesions of the uterus and its solutions using artificial intelligence.
     PLoS One. 2024;19:e0315862.
     PubMed     Abstract available
     
     
     January 2023
200. RODRIGUEZ NM, Brennan LP, Claure L, Balian LN, et al
     Leveraging COVID-era innovation for cervical cancer screening: Clinician awareness and attitudes toward self-sampling and rapid testing for HPV detection.
     PLoS One. 2023;18:e0282853.
     PubMed     Abstract available
     
     
     
201. YAN L, Xiao X, He L, Shi L, et al
     Efficacy of optical coherence tomography in the triage of women with minor abnormal cervical cytology before colposcopy.
     PLoS One. 2023;18:e0282833.
     PubMed     Abstract available
     
     
     
202. CHOI J, Markham C, Tami-Maury I, Kim S, et al
     Maternal perceptions of vaccinating boys against human papillomavirus (HPV) in Seoul, South Korea: A descriptive exploratory qualitative study.
     PLoS One. 2023;18:e0282811.
     PubMed     Abstract available
     
     
     
203. GIBSON-HELM M, Slater T, MacDonald EJ, Stevenson K, et al
     Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
     PLoS One. 2023;18:e0280643.
     PubMed     Abstract available
     
     
     
204. SMITH JS, Vaz OM, Gaber CE, Des Marais AC, et al
     Recruitment strategies and HPV self-collection return rates for under-screened women for cervical cancer prevention.
     PLoS One. 2023;18:e0280638.
     PubMed     Abstract available
     
     
     
205. TAKADA A, Yokota H, Nemoto MW, Horikoshi T, et al
     Prognosis prediction of uterine cervical cancer using changes in the histogram and texture features of apparent diffusion coefficient during definitive chemoradiotherapy.
     PLoS One. 2023;18:e0282710.
     PubMed     Abstract available
     
     
     
206. PAKEN J, Govender CD, Pillay M, Feyasa M, et al
     Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa.
     PLoS One. 2023;18:e0283639.
     PubMed     Abstract available
     
     
     
207. LIVESEY M, Rossouw SC, Blignaut R, Christoffels A, et al
     Transforming RNA-Seq gene expression to track cancer progression in the multi-stage early to advanced-stage cancer development.
     PLoS One. 2023;18:e0284458.
     PubMed     Abstract available
     
     
     
208. 
     Expression of Concern: Prognostic Impact of Epidermal Growth Factor Receptor Overexpression in Patients with Cervical Cancer: A Meta-Analysis.
     PLoS One. 2023;18:e0285579.
     PubMed    
     
     
     
209. HOLOPAINEN E, Lahtinen O, Kononen M, Anttila M, et al
     Greater increases in intratumoral apparent diffusion coefficients after chemoradiotherapy predict better overall survival of patients with cervical cancer.
     PLoS One. 2023;18:e0285786.
     PubMed     Abstract available
     
     
     
210. OKAFOR IP, Kukoyi FO, Kanma-Okafor OJ, Izuka MO, et al
     Male involvement in female partners' screening for breast and cervical cancers in Southwest Nigeria.
     PLoS One. 2023;18:e0284141.
     PubMed     Abstract available
     
     
     
211. MITI S, Shato T, Asante C, Baumann A, et al
     Leveraging health infrastructure to optimize HPV vaccination for adolescents in Zambia: Protocol for an implementation study.
     PLoS One. 2023;18:e0285031.
     PubMed     Abstract available
     
     
     
212. KHOMPHAIBOONKIJ U, Sreamsukcharoenchai N, Pitakkarnkul S, Rittiluechai K, et al
     Knowledge of Thai women in cervical cancer etiology and screening.
     PLoS One. 2023;18:e0286011.
     PubMed     Abstract available
     
     
     
213. KURITA Y, Meguro S, Tsuyama N, Kosugi I, et al
     Accurate deep learning model using semi-supervised learning and Noisy Student for cervical cancer screening in low magnification images.
     PLoS One. 2023;18:e0285996.
     PubMed     Abstract available
     
     
     
214. PANERU B, Karmacharya A, Bharati A, Makaju S, et al
     Association between cancer stigma and cervical cancer screening uptake among women of Dhulikhel and Banepa, Nepal.
     PLoS One. 2023;18:e0285771.
     PubMed     Abstract available
     
     
     
215. JEMAL Z, Chea N, Hasen H, Tesfaye T, et al
     Cervical cancer screening utilization and associated factors among female health workers in public health facilities of Hossana town, southern Ethiopia: A mixed method approach.
     PLoS One. 2023;18:e0286262.
     PubMed     Abstract available
     
     
     
216. MWENDA V, Bor JP, Nyangasi M, Njeru J, et al
     Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
     PLoS One. 2023;18:e0286202.
     PubMed     Abstract available
     
     
     
217. FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al
     Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial.
     PLoS One. 2023;18:e0286909.
     PubMed     Abstract available
     
     
     
218. ALAM Z, Cairns JM, Scott M, Dean JA, et al
     Interventions to increase cervical screening uptake among immigrant women: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0281976.
     PubMed     Abstract available
     
     
     
219. VAINER G, Huang L, Emancipator K, Nuti S, et al
     Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indications.
     PLoS One. 2023;18:e0285764.
     PubMed     Abstract available
     
     
     
220. JONSDOTTIR B, Wikman A, Sundstrom Poromaa I, Stalberg K, et al
     Advanced gynecological cancer: Quality of life one year after diagnosis.
     PLoS One. 2023;18:e0287562.
     PubMed     Abstract available
     
     
     
221. STRBAC M, Vukovic V, Pustahija T, Nikolic N, et al
     Motives and attitudes of parents toward HPV vaccination: Results from the initial period of HPV vaccine rollout in Serbia.
     PLoS One. 2023;18:e0287295.
     PubMed     Abstract available
     
     
     
222. WULANDARI D, Meidyandra RW, Andrijono
     Genotype profiles of high-risk human papillomavirus in women of reproductive age: A community-based study.
     PLoS One. 2023;18:e0287399.
     PubMed     Abstract available
     
     
     
223. MAHAJAN H, Reddy N, Devi NGM, Poli UR, et al
     Projected cancer burden, challenges, and barriers to cancer prevention and control activities in the state of Telangana.
     PLoS One. 2023;18:e0278357.
     PubMed     Abstract available
     
     
     
224. FAZLOLLAHPOUR-NAGHIBI A, Bagheri K, Almukhtar M, Taha SR, et al
     Trichomonas vaginalis infection and risk of cervical neoplasia: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0288443.
     PubMed     Abstract available
     
     
     
225. BAS S, Sijben J, Bischoff EWMA, Bekkers RLM, et al
     Acceptability of risk-based triage in cervical cancer screening: A focus group study.
     PLoS One. 2023;18:e0289647.
     PubMed     Abstract available
     
     
     
226. CONTRERAS NE, Roldan JS, Castillo DS
     Novel competitive enzyme-linked immunosorbent assay for the detection of the high-risk Human Papillomavirus 18 E6 oncoprotein.
     PLoS One. 2023;18:e0290088.
     PubMed     Abstract available
     
     
     
227. CHONA EZ, Msengi EA, Gosse RA, Ambikile JS, et al
     The lived experiences and caring needs of women diagnosed with cervical cancer: A qualitative study in Dar es Salaam, Tanzania.
     PLoS One. 2023;18:e0289925.
     PubMed     Abstract available
     
     
     
228. OKYERE ASANTE PG, Owusu AY, Oppong JR, Amegah KE, et al
     The psychosocial burden of women seeking treatment for breast and cervical cancers in Ghana's major cancer hospitals.
     PLoS One. 2023;18:e0289055.
     PubMed     Abstract available
     
     
     
229. GONG M, Shen F, Li Y, Ming L, et al
     MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
     PLoS One. 2023;18:e0290462.
     PubMed     Abstract available
     
     
     
230. URQUHART G, Maclennan SJ, Guntupalli AM
     Is there an association between intimate partner violence and the prevalence of cervical cancer screening in Jordan?
     PLoS One. 2023;18:e0290678.
     PubMed     Abstract available
     
     
     
231. SUNDARA RAJAN R S, Thomas J, Francis D, Daniel EC, et al
     Effective gene delivery using size dependant nano core-shell in human cervical cancer cell lines by magnetofection.
     PLoS One. 2023;18:e0289731.
     PubMed     Abstract available
     
     
     
232. ODEH HI, Al-Badi SR, Karima B, Saeed TA, et al
     Exploring the prevalence of Human Papillomavirus (HPV) genotypes in PAP smear samples of women in northern region of United Arab Emirates (UAE): HPV Direct Flow CHIP system-based pilot study.
     PLoS One. 2023;18:e0286889.
     PubMed     Abstract available
     
     
     
233. WANG S, Wang Y, Zhuang J, Wu Y, et al
     Prognostic significance of index (LANR) composed of preoperative lymphocytes, albumin, and neutrophils in patients with stage IB-IIA cervical cancer.
     PLoS One. 2023;18:e0290905.
     PubMed     Abstract available
     
     
     
234. MANTULA F, Toefy Y
     Women and health providers' perspectives on male support for cervical cancer screening in Gwanda district, Zimbabwe.
     PLoS One. 2023;18:e0282931.
     PubMed     Abstract available
     
     
     
235. IORDANISHVILI S, Metreveli T, Lipartia E, Gachechiladze K, et al
     The HPV-TP53-MALAT1 Axis: Unravelling interactions in cervical cancer development.
     PLoS One. 2023;18:e0291725.
     PubMed     Abstract available
     
     
     
236. FERREIRA HNC, Capistrano GN, Morais TNB, Costa KTDS, et al
     Screening and hospitalization of breast and cervical cancer in Brazil from 2010 to 2022: A time-series study.
     PLoS One. 2023;18:e0278011.
     PubMed     Abstract available
     
     
     
237. QAQISH A, Abdo N, Abbas MM, Saadeh N, et al
     Awareness and knowledge of physicians and residents on the non-sexual routes of human papilloma virus (HPV) infection and their perspectives on anti-HPV vaccination in Jordan.
     PLoS One. 2023;18:e0291643.
     PubMed     Abstract available
     
     
     
238. ZHAO X, Gopalappa C
     Joint modeling HIV and HPV using a new hybrid agent-based network and compartmental simulation technique.
     PLoS One. 2023;18:e0288141.
     PubMed     Abstract available
     
     
     
239. DESTA M, Getaneh T, Yeserah B, Worku Y, et al
     Correction: Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0294799.
     PubMed     Abstract available
     
     
     
240. TACHIWENYIKA E, Dhodho M, Muchedzi A, Sibanda TP, et al
     Prevalence of Cervical Cancer and Clinical Management of Women Screened positive using visual inspection with acetic acid and Cervicography in selected public sector health facilities of Manicaland and Midlands provinces of Zimbabwe, 2021.
     PLoS One. 2023;18:e0294115.
     PubMed     Abstract available
     
     
     
241. MAHUMUD RA, Alam K, Dunn J, Gow J, et al
     Correction: The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia.
     PLoS One. 2023;18:e0295688.
     PubMed     Abstract available
     
     
     
242. QULU W, Mtshali A, Osman F, Ndlela N, et al
     High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV.
     PLoS One. 2023;18:e0294698.
     PubMed     Abstract available
     
     
     
243. ALMASOUDI HH, Nahari MH, Alhazmi AYM, Almasabi SHA, et al
     Delineating Pixantrone Maleate's adroit activity against cervical cancer proteins through multitargeted docking-based MM\GBSA, QM-DFT and MD simulation.
     PLoS One. 2023;18:e0295714.
     PubMed     Abstract available
     
     
     
244. RAZZAK MA, Islam MN, Aadeeb MS, Tasnim T, et al
     Digital health interventions for cervical cancer care: A systematic review and future research opportunities.
     PLoS One. 2023;18:e0296015.
     PubMed     Abstract available
     
     
     
245. AL-OSEELY S, Abdul Manaf R, Ismail S
     Factors affecting cervical cancer screening among Yemeni immigrant women in Klang Valley, Malaysia: A cross sectional study.
     PLoS One. 2023;18:e0290152.
     PubMed     Abstract available
     
     
     
246. GEBREMESKEL TG, Gebretatios MZ
     Determinants of cervical cancer screening utilization among HIV-positive women, in public general hospitals of Central Zone, Tigray, Ethiopia, 2020: Case-control study.
     PLoS One. 2023;18:e0289042.
     PubMed     Abstract available
     
     
     
247. NOVAIS IR, Coelho CO, Machado HC, Surita F, et al
     Cervical cancer screening in Brazilian Amazon Indigenous women: Towards the intensification of public policies for prevention.
     PLoS One. 2023;18:e0294956.
     PubMed     Abstract available
     
     
     
248. TOSADO-RODRIGUEZ E, Mendez LB, Espino AM, Dorta-Estremera S, et al
     Inflammatory cytokines and a diverse cervicovaginal microbiota associate with cervical dysplasia in a cohort of Hispanics living in Puerto Rico.
     PLoS One. 2023;18:e0284673.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum